STOCK TITAN

[SCHEDULE 13G/A] ClearPoint Neuro, Inc. Amended Passive Investment Disclosure

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Bigger Capital Fund LP and related entities filed an amended Schedule 13G reporting their beneficial ownership of ClearPoint Neuro, Inc. common stock as of February 4, 2026. Bigger Capital and its general partner Bigger Capital Fund GP, LLC report beneficial ownership of 1,333,155 shares, or about 4.69% of the outstanding stock.

District 2 Capital Fund LP and its affiliated entities report beneficial ownership of 337,696 shares, or about 1.19%. Michael Bigger may be deemed to beneficially own about 7.8% of the common stock, including interests attributed through these funds and family holdings. The percentages are based on 28,423,308 shares outstanding as of October 27, 2025, and the filers certify the holdings are not for the purpose of changing or influencing control of ClearPoint Neuro.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



BIGGER CAPITAL FUND L P
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member of Bigger Capital Fund GP, LLC, its general partner
Date:02/04/2026
Bigger Capital Fund GP, LLC
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member
Date:02/04/2026
District 2 Capital Fund LP
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member of District 2 GP LLC, its general partner
Date:02/04/2026
District 2 Capital LP
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member
Date:02/04/2026
District 2 GP LLC
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member
Date:02/04/2026
District 2 Holdings LLC
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member
Date:02/04/2026
Bigger Michael
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger
Date:02/04/2026
Patricia Winter
Signature:/s/ Patricia Winter
Name/Title:Patricia Winter
Date:02/04/2026

FAQ

What does Bigger Capital disclose in this Schedule 13G/A for ClearPoint Neuro (CLPT)?

Bigger Capital and affiliated entities disclose passive beneficial ownership of ClearPoint Neuro common stock. They report combined positions through funds and related parties, detailing share counts, voting and dispositive power, and ownership percentages based on the company’s reported shares outstanding as of October 27, 2025.

How many ClearPoint Neuro (CLPT) shares does Bigger Capital beneficially own and what percentage is this?

Bigger Capital Fund LP reports beneficial ownership of 1,333,155 ClearPoint Neuro common shares. Based on 28,423,308 shares outstanding, this represents approximately 4.69% of the company’s common stock, with shared voting and dispositive power reported together with its general partner Bigger Capital Fund GP, LLC.

What ClearPoint Neuro (CLPT) stake is attributed to Michael Bigger personally and through related entities?

Michael Bigger may be deemed to beneficially own about 7.8% of ClearPoint Neuro common stock. This includes shares held by Bigger Capital, District 2 Capital Fund, his IRA account, his spouse Patricia Winter, and his sons, although multiple parties expressly disclaim beneficial ownership of others’ shares.

What ownership does District 2 Capital Fund report in ClearPoint Neuro (CLPT)?

District 2 Capital Fund LP reports beneficial ownership of 337,696 ClearPoint Neuro common shares. Using 28,423,308 shares outstanding, this equals about 1.19% of the company. Related entities District 2 Capital LP, District 2 GP LLC, and District 2 Holdings LLC may each be deemed to beneficially own the same shares.

On what share count and dates are the ClearPoint Neuro (CLPT) ownership percentages based?

All reported ownership percentages are calculated using 28,423,308 ClearPoint Neuro common shares outstanding as of October 27, 2025. Beneficial ownership positions for Bigger Capital, District 2 entities, Michael Bigger, and Patricia Winter are stated as of February 4, 2026, reflecting holdings on that later reference date.

Is the ClearPoint Neuro (CLPT) stake reported by Bigger Capital intended to influence control of the company?

The reporting persons certify their ClearPoint Neuro holdings were not acquired and are not held for the purpose of changing or influencing control of the issuer. They also state the securities are not held in connection with any transaction having that purpose, other than activities tied to certain proxy nomination rules.
Clearpoint Neuro Inc

NASDAQ:CLPT

CLPT Rankings

CLPT Latest News

CLPT Latest SEC Filings

CLPT Stock Data

395.95M
26.05M
8.19%
38.99%
8.25%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SOLANA BEACH